2021
DOI: 10.1080/09273948.2021.1962916
|View full text |Cite
|
Sign up to set email alerts
|

Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy

Abstract: Purpose: To investigate the role of combined systemic and local chemotherapy in improving the survival of patients with vitreoretinal lymphoma (VRL). Methods: Patients with VRL consecutively seen from 2006 to 2020 were retrospectively reviewed; data on the presence and time of central nervous system (CNS) involvement and treatment regimen (systemic, local or combined chemotherapy) were collected. Overall survival (OS) and progression-free survival (PFS) were calculated for each group. Results: Forty-three eyes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…It must be emphasised that patients later found to be affected by VRL are being referred more frequently to a uveitis specialist because these tumours may mimic inflammatory eye disease [42]. For this reason, recognising VRL, especially, in differential diagnosis with uveitis is a great challenge; the high rate of diagnostic delay worsens not only the visual prognosis, it also, and more importantly, shortens the patient's life [2]. It is important to objectively discriminate between vitreous infiltration in VRL and vitreous inflammation in uveitis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It must be emphasised that patients later found to be affected by VRL are being referred more frequently to a uveitis specialist because these tumours may mimic inflammatory eye disease [42]. For this reason, recognising VRL, especially, in differential diagnosis with uveitis is a great challenge; the high rate of diagnostic delay worsens not only the visual prognosis, it also, and more importantly, shortens the patient's life [2]. It is important to objectively discriminate between vitreous infiltration in VRL and vitreous inflammation in uveitis.…”
Section: Discussionmentioning
confidence: 99%
“…Vitreoretinal lymphoma (VRL) is the most common uveitis masquerade syndrome and thus a diagnostic challenge [1]. The insidious clinical presentation as chronic and recurrent uveitis, combined with the transient response to lymphocytolytic steroids, leads to diagnostic and therapeutic delay, often resulting in a poor prognosis with high mortality if the central nervous system (CNS) is involved [2]. Therefore, a timely and accurate diagnosis is essential to improve the prognosis of patients with VRL, and overcoming the difficulties encountered in its diagnosis is an urgent need [3].…”
Section: Introductionmentioning
confidence: 99%
“…A PVRL may develop as an isolated entity or present before or simultaneously with a central nervous system (CNS) lymphoma [ 4 ]. After 16–24 months from PVRL diagnosis, 56–90% of patients develop CNS involvement [ 5 ].…”
Section: Introductionmentioning
confidence: 99%